Related references
Note: Only part of the references are listed.Dissemination and Characteristics of a Novel Plasmid-Encoded Carbapenem-Hydrolyzing Class D beta-Lactamase, OXA-436, Found in Isolates from Four Patients at Six Different Hospitals in Denmark
Orjan Samuelsen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae
M. Souli et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case-control study
Gennaro De Pascale et al.
CRITICAL CARE (2017)
Resistance to Ceftazidime-Avibactam in Klebsiella pneumoniae Due to Porin Mutations and the Increased Expression of KPC-3
Romney M. Humphries et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae
Laurent Poirel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
In Vitro Susceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014)
Boudewijn L. M. de Jonge et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Emergence of Klebsiella pneumoniae co-producing OXA-48, CTX-M-15, and ArmA in Greece
I. Galani et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods
Chang-Ro Lee et al.
FRONTIERS IN MICROBIOLOGY (2016)
Genetic and Biochemical Characterization of OXA-405, an OXA-48-Type Extended-Spectrum β-Lactamase without Significant Carbapenemase Activity
Laurent Dortet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Efficacy of Humanized Carbapenem and Ceftazidime Regimens against Enterobacteriaceae Producing OXA-48 Carbapenemase in a Murine Infection Model
Dora E. Wiskirchen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Treating infections caused by carbapenemase-producing Enterobacteriaceae
L. S. Tzouvelekis et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections
Alessandra Oliva et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge
C. Navarro-San Francisco et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak
Jose Ramon Pano-Pardo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
First Clinical Cases of OXA-48-Producing Carbapenem-Resistant Klebsiella pneumoniae in the United States: the Menace Arrives in the New World
Amy J. Mathers et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Broad-Spectrum β-Lactam Antibiotics for Treating Experimental Peritonitis in Mice Due to Klebsiella pneumoniae Producing the Carbapenemase OXA-48
Olivier Mimoz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
OXA-48-like carbapenemases: the phantom menace
Laurent Poirel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
Catharine C. Bulik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Crystal Structure of the OXA-48 β-Lactamase Reveals Mechanistic Diversity among Class D Carbapenemases
Jean-Denis Docquier et al.
CHEMISTRY & BIOLOGY (2009)
Pharmacokinetic and pharmacodynamic properties of meropenem
David P. Nicolau
CLINICAL INFECTIOUS DISEASES (2008)
Two decades of imipenem therapy
A. C. Rodloff et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae
L Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians
DE Nix et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Share Paper
